Lexicon Genetics Incorporated
8800 Technology Forest Place
The Woodlands
Texas
77381
United States
Tel: 281-863-3000
Fax: 281-863-8088
Website: http://www.lexicon-genetics.com/
Email: cschultz@lexgen.com
54 articles about Lexicon Genetics Incorporated
-
Lexicon Genetics Incorporated to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009
11/23/2009
-
Lexicon Genetics Incorporated Initiates Phase 2 Clinical Trial of LX2931 in Patients With Rheumatoid Arthritis
8/4/2009
-
Lexicon Genetics Incorporated Files Investigational New Drug Application for LX2931 as a Potential Treatment for Rheumatoid Arthritis
11/12/2007
-
Lexicon Genetics Incorporated to Present at the Biotechnology Industry Organization (BIO) 2007 International Convention
5/7/2007
-
Lexicon Genetics Incorporated Changes Name to Lexicon Pharmaceuticals as Drug Development Pipeline Progresses
4/26/2007
-
Lexicon Genetics Incorporated Advances LX1031 for Irritable Bowel Syndrome Into Phase 1b Clinical Trial
4/24/2007
-
Lexicon Genetics Incorporated to Present at the Morgan Stanley Global Healthcare Unplugged Conference
4/23/2007
-
Lexicon Genetics Incorporated to Report First Quarter 2007 Financial Results on May 1, 2007; Conference Call and Webcast to Follow
4/13/2007
-
Lexicon Genetics Incorporated Appoints Tamar Howson Executive Vice President of Business Development
3/20/2007
-
Lexicon Genetics Incorporated Elects Kathleen Wiltsey to Board of Directors
2/28/2007
-
Lexicon Genetics Incorporated Reports 2006 Fourth Quarter And Full Year Financial Results
2/21/2007
-
The Week In Review: Biotech Treks Higher
2/5/2007
-
The Day In Review: Alfacell Receives Orphan Drug Status For Onconase
1/30/2007
-
Lexicon Genetics Incorporated Initiates Clinical Trials Of LX1031 For Irritable Bowel Syndrome
1/24/2007
-
Lexicon Genetics Incorporated To Present At RBC Capital Markets Healthcare Conference
12/8/2006
-
The Day In Review: More Success For Acomplia From Sanofi-Aventis (France)
12/5/2006
-
Lexicon Genetics Incorporated Files Investigational New Drug Application For LX1031 In Irritable Bowel Syndrome
12/5/2006
-
Webcast Alert: Lexicon Genetics Incorporated Announces Webcast Of Annual Analyst And Investor Luncheon
12/4/2006
-
Lexicon Genetics Incorporated To Present At Rodman & Renshaw 8th Annual Healthcare Conference
11/2/2006
-
Lexicon Genetics Incorporated Reports 2006 Third Quarter Financial Results
10/31/2006